Hypovitaminosis D, neighborhood poverty, and progression of chronic kidney disease in disadvantaged populations

Clinical Nephrology

Volumn 74, Issue SUPPL.1, 2010, Pages

  Mehrotra, R ^a,b   Norris, K ^b  

^a Harbor UCLA Los Angeles Biomedical Research Institute   (United States)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Diabetes; Genetic predisposition; Hypertension; Neighbourhood poverty; Renal disparities; Vitamin D deficiency

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; HUMAN; NEGRO; POVERTY; UNITED STATES; VITAMIN D DEFICIENCY; VULNERABLE POPULATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; POVERTY; UNITED STATES; VITAMIN D DEFICIENCY; VULNERABLE POPULATIONS;

EID: 79952277166     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. United States Renal Data System. US Department of Public Health and Human Services, National Institutes of Health. Bethesda: Public Health Service; 2008.
2. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003; 41: 1-12.
3. Mehrotra R, Kermah D, Fried LF et al. Racial differences in mortality among those with CKD. J Am Soc Nephrol. 2008; 19: 1403-1410.
4. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-281.
5. Artaza JN, Mehrotra R, Norris KC. VitaminD and the cardiovascular system. Clin JAmSoc Nephrol. 2009: (in press).
6. Zadshir A, Tareen N, Pan D et al. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis. 2005; 15: 5-97-101.
7. Harinarayan CV, Ramalakshmi T, Prasad UV et al. Vitamin D status in Andhra Pradesh: a population based study. Indian J Med Res. 2008; 127: 211-218.
8. Mehrotra R, Kermah D, Budoff Met al. Hypovitaminosis D and chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 1144-1151.
9. Mehrotra R, Kermah D, Salusky I, Wolf M, Thadhani R, Chiu YW, Martins D, Adler SA, Norris K. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009; 76: 977-983.
10. Tian J, Liu Y,Williams LAet al. Potential role of active vitamin D in retarding the progression of chronic kidney disease. Nephrol Dial Transplant. 2007; 22: 321-328.
11. Agarwal R, Acharya M, Tian J et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 2005; 68: 2823-2828.
12. Alborzi P, Patel NA, Peterson C et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension. 2008; 52: 249-255.
13. Szeto CC, Chow KM, Kwan BC et al. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial. Am J Kidney Dis. 2008; 51: 724-731.
14. Gee GC, Payne-Sturges DC. Environmental health disparities: a framework integrating psychosocial and environmental concepts. Environ Health Perspect. 2004; 112: 1645-1653.
15. Volkova N, McClellan W, Klein Met al. Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol. 2008; 19: 356-364.
16. Cass A, Cunningham J,Wang Z et al. Social disadvantage and variation in the incidence of end-stage renal disease in Australian capital cities. Aust N Z J Public Health. 2001; 25: 322-326.
17. Maheswaran R, Pearson T, Jordan H et al. Socioeconomic deprivation, travel distance, location of service, and uptake of breast cancer screening in North Derbyshire, UK. J Epidemiol Community Health. 2006; 60: 208-212.
18. Ward MM. Socioeconomic status and the incidence of ESRD. Am J Kidney Dis. 2008; 51: 563-572.
19. Fored CM, Ejerblad E, Fryzek JP et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant. 2003; 18: 82-88.
20. Bello AK, Peters J, Rigby J et al. Socioeconomic status and chronic kidney disease at presentation to a renal service in the United Kingdom. Clin J Am Soc Nephrol. 2008; 3: 1316-1323.
21. Shoham DA, Vupputuri S, Kaufman JS et al. Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study. Soc Sci Med. 2008; 67: 1311-1320.
22. Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int. 2005; 68: 914-924.